Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 16451-16500 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05777512
Randomized Controlled Crossover Trial of Postpyloric Feedings to Improve Pulmonary Outcomes in High-risk Preterm Infants
NARecruiting
50 participants
Started: Oct 31, 2024 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT06545045
Cognitive Rehabilitation Following Breast Cancer Treatment
NARecruiting
50 participants
Started: Oct 31, 2024 · Completed: Dec 30, 2025
1 condition3 sponsors1 location
NCT06678919
AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond
N/ARecruiting
500 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2034
1 condition1 sponsor7 locations
NCT06597435
Effects of Nicotine Pouch Characteristics on Perceptions and Behavior
NARecruiting
72 participants
Started: Oct 31, 2024 · Completed: Jul 31, 2025
1 condition2 sponsors2 locations
NCT06612320
Refusal to Participate in a Randomized Trial Involving Pregnancy and Childbirth: Factors Associated with Refusal and Reasons for Refusal and Acceptance
N/ARecruiting
720 participants
Started: Oct 31, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor4 locations
NCT06647251
Comparison of 3 RF Delivery Modes of the QDOT Catheter for Paroxymal Atrial Fibrillation (AF) Ablation
NARecruiting
90 participants
Started: Oct 31, 2024 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT06594276
Comparison of Efficacy in Treating Breast Abscess, With Systemic Antibiotics Against Local Instillation of Antibiotics Along With Ultrasound Guided Aspiration.
NARecruiting
104 participants
Started: Oct 31, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT06578650
A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms
N/ARecruiting
34 participants
Started: Oct 31, 2024 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT06496256
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
NARecruiting
84 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2027
1 condition2 sponsors5 locations
NCT06666387
The New Combined PET-MR System NextGen PET-MR With Syngo MR XA80A: Evaluation of Diagnostic Image Quality and Usability (Software and Hardware) in the Clinical Setting.
NARecruiting
60 participants
Started: Oct 31, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06727708
Comparison of Two BioCircuit Programs: Impact on Physical Fitness and Body Composition in Adults Aged 30-65
NARecruiting
42 participants
Started: Oct 31, 2024 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT06667921
Ultrasonographic Airway Assessment in Predicting Difficult Laryngoscopy in Pediatric Patients Undergoing Elective Surgery
N/ARecruiting
308 participants
Started: Oct 31, 2024 · Completed: Sep 1, 2025
5 conditions1 sponsor1 location
NCT06607692
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
PHASE2Recruiting
25 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2029
9 conditions1 sponsor1 location
NCT06617455
Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial
PHASE2Recruiting
36 participants
Started: Oct 31, 2024 · Completed: Oct 1, 2026
5 conditions2 sponsors1 location
NCT06610877
Ultrasound Neuromodulation in Essential Tremor
NARecruiting
60 participants
Started: Oct 31, 2024 · Completed: Mar 31, 2027
2 conditions2 sponsors1 location
NCT06732492
RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies
PHASE1Recruiting
10 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT06638398
Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules
NARecruiting
400 participants
Started: Oct 31, 2024 · Completed: Dec 1, 2027
1 condition2 sponsors5 locations
NCT06919328
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
NARecruiting
70 participants
Started: Oct 31, 2024 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT06654986
Muscle Anabolic Response to β2-adrenergic Stimulation With Increased Amino Acid Availability.
NARecruiting
36 participants
Started: Oct 31, 2024 · Completed: Dec 18, 2026
1 condition1 sponsor1 location
NCT06655012
Salmeterol Effect on Exercise Performance
NARecruiting
36 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06657547
Urinary Concentration After Salmeterol
NARecruiting
24 participants
Started: Oct 31, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06180382
Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.
PHASE4Recruiting
220 participants
Started: Oct 31, 2024 · Completed: Jan 31, 2027
1 condition2 sponsors12 locations
NCT06298188
Risankizumab in Children With Crohn's Disease (RisaKids)
NARecruiting
90 participants
Started: Oct 31, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06576037
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
PHASE1Recruiting
128 participants
Started: Oct 31, 2024 · Completed: Jun 1, 2029
1 condition1 sponsor1 location
NCT06434207
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
N/ARecruiting
10 participants
Started: Oct 31, 2024 · Completed: Dec 1, 2026
3 conditions1 sponsor1 location
NCT06434194
Serrantor OCT Study
NARecruiting
60 participants
Started: Oct 31, 2024 · Completed: Jun 1, 2025
1 condition1 sponsor2 locations
NCT06626646
Vascular Regenerative Cell Exhaustion in Adults with Peripheral Artery Disease (PAD-VRCE)
N/ARecruiting
40 participants
Started: Oct 31, 2024 · Completed: Jul 31, 2025
4 conditions1 sponsor2 locations
NCT06767254
A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence
N/ARecruiting
200 participants
Started: Oct 30, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor4 locations
NCT05283382
Cannabidiol Effects on Learning and Anxiety
EARLY_PHASE1Recruiting
160 participants
Started: Oct 30, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06679387
"The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients"
PHASE2Recruiting
80 participants
Started: Oct 30, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06555744
A Study of ZW191 in Participants With Solid Tumors
PHASE1Recruiting
145 participants
Started: Oct 30, 2024 · Completed: Jan 31, 2027
1 condition1 sponsor18 locations
NCT06686108
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
PHASE2Recruiting
59 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2028
3 conditions1 sponsor1 location
NCT06691152
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
PHASE1Recruiting
18 participants
Started: Oct 30, 2024 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT06541704
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
PHASE3Recruiting
975 participants
Started: Oct 30, 2024 · Completed: May 21, 2032
2 conditions1 sponsor110 locations
NCT06972199
Reflexology Massage and Hot Water Foot Bath for Pain and GI Recovery After Colorectal Surgery
NARecruiting
102 participants
Started: Oct 30, 2024 · Completed: Jun 30, 2026
4 conditions1 sponsor2 locations
NCT06682572
A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients
PHASE2Recruiting
15 participants
Started: Oct 30, 2024 · Completed: Oct 31, 2027
2 conditions2 sponsors5 locations
NCT06570278
Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NARecruiting
1,020 participants
Started: Oct 30, 2024 · Completed: Nov 30, 2034
1 condition10 sponsors26 locations
NCT06656949
Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer
NARecruiting
42 participants
Started: Oct 30, 2024 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT05993845
Modeling and Workflow Recognition for the Anterior Approach in Total Hip Arthroplasty
N/ARecruiting
60 participants
Started: Oct 30, 2024 · Completed: Dec 30, 2025
1 condition3 sponsors3 locations
NCT06601335
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
PHASE3Recruiting
510 participants
Started: Oct 30, 2024 · Completed: Oct 31, 2027
1 condition1 sponsor2 locations
NCT06689852
CLINICAL INVESTIGATION FOR THE EVALUATION OF EFFICACY AND SAFETY OF TWO PRODUCTS FOR THE TREATMENT OF ONYCHOMYCOSIS
NARecruiting
88 participants
Started: Oct 30, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT07169214
Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding
PHASE1Recruiting
36 participants
Started: Oct 30, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06453512
A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema
NARecruiting
65 participants
Started: Oct 30, 2024 · Completed: Oct 1, 2025
1 condition3 sponsors1 location
NCT06561321
Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma
PHASE2Recruiting
6 participants
Started: Oct 30, 2024 · Completed: Nov 1, 2026
1 condition2 sponsors1 location
NCT06468332
Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer
N/ARecruiting
400 participants
Started: Oct 30, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06642311
Bladder Distension for Pain Relief in Patients With Excessive Anteflexion of Uterus Undergoing Office Hysteroscopy
NARecruiting
48 participants
Started: Oct 30, 2024 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT06647732
Zanubrutinib Plus Rituximab As Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT)
PHASE2Recruiting
42 participants
Started: Oct 30, 2024 · Completed: Sep 30, 2028
1 condition8 sponsors1 location
NCT06541184
Ziconotide for Non-cancer Pain by Intrathecal Administration
N/ARecruiting
85 participants
Started: Oct 30, 2024 · Completed: Oct 30, 2029
1 condition1 sponsor14 locations
NCT05949177
Graded Exposure and Mindfulness Meditation for Patients Post-ACL Reconstruction
NARecruiting
50 participants
Started: Oct 30, 2024 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT06602232
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
PHASE1Recruiting
80 participants
Started: Oct 30, 2024 · Completed: Sep 30, 2026
2 conditions1 sponsor20 locations